Nye C, Brice A.  2005.  Combined Vitamin B6-Magnesium Treatment in Autism Spectrum Disorder. Cochrane Database Syst Rev.. 19(4):CD003497.

Nwora AJ, Gee BM.  2009.  A Case Study of a Five-year-old Child with Pervasive Developmental Disorder-Not Otherwise Specified Using Sound-Based Interventions. Occupational Therapy International. 16(1):25-43.

Nunes D, Hanline MF.  2007.  Enhancing the Alternative and Augmentative Communication Use of a Child with Autism through a Parent-implemented Naturalistic Intervention. International Journal of Disability, Development and Education. 54(2):177-197.

Nunes DRP.  2008.  AAC Interventions for Autism: A Research Summary. International Journal for Autism: A Research Summary. 23(2):17-26.

Novaes CM, Ponde MP, Freire ACC.  2008.  Control of Psychomotor Agitation and Aggressive Behavior in Patients with Autistic Disorder: A Retrospective Chart Review. Arq Neuropsiquiatr. 66(3B):646-651.

Nilsson BM, Ekselius L.  2009.  Acute and Maintenance Electroconvulsive Therapy for Treatment of Severely Disabling Obsessive-Compulsive Symptoms in a Patient with Asperger Syndrome. Journal of ECT. 25(3):205-207. Abstract

Nikopoulos CK, Canavan C, Nikopoulou-Smyrni P.  2009.  Generalized Effects of Video Modeling on Establishing Instructional Stimulus Control in Children with Autism. Journal of Positive Behavior Interventions. 11(4):198-207. Abstract

Nikopoulos CK, Keenan M.  2007.  Using Video Modeling to Teach Complex Social Sequences to Children with Autism. J Autism Dev Disord. 37(4):678-693.

NietodelRincon PL.  2008.  Autism: Alterations in Auditory Perception. Reviews in the Neuroscience. 19(1):61-78.

Niederhofer H.  2007.  Treating Autism Pharmacologically: Also Tacrine Might Improve Symptomology in Some Cases. Journal of Child Neurology. 22(8):1054-1057.

Niederhofer H.  2006.  Atomoxetine Treating Patients with Autistic Disorder. Autism. 10(6):647-650.

Niederhofer H.  2006.  Atomoxetine: Treating Patients with Autistic Disorder. Autism. 10(6):647-650.

Niederhofer H.  2007.  Glutamate Antagonists Seem to be Slightly Effective in Psychopharmacologic Treatment of Autism. Journal of Clinical Psychopharmacology. 27(3):317-318.

Nicolson GL, Gan R, Nicolson NL, Haier J.  2007.  Evidence for Mycoplasma ssp., Chlamydia pneumoniae, and Human Herpes Virus-6 Coinfections in the Blood of Patients with Autistic Spectrum Disorders. Journal of Neuroscience Research. 85(5):1143-1148.

Nicolson R, Craven-Thuss B, Smith J.  2006.  A Prospective, Open-Label Trial of Galantamine in Autistic Disorder. Journal of Child and Adolescent Psychopharmacology. 16(5):621-629.

Nickels KC, Katusic SK, Colligan RC, Weaver AL, Voigt RG, Barbaresi WJ.  2008.  Stimulant Medication Treatment of Target Behaviors in Children with Autism: A Population-Based Study. J Dev Behav Pediatr. 29:75-81.

Newmeyer A, deGrauw T, Clark J, Chuck G, Salomons G.  2007.  Screening of Male Patients with Autism Spectrum Disorder for Creatine Transporter Deficiency. Neuropediatrics. 38(6):310-312.

Neumann ID.  2008.  Brain Oxytocin: A Key Regulator of Emotional and Social Behaviors in Both Females and Males. Journal of Neuroendocrinology. 20(6):858-865.

Naoi N, Tsuchiya R, Yamamoto J-I, Nakamura K.  2008.  Functional Training for Initiating Joint Attention in Children with Autism. Research in Developmental Disabilities. 29(6):595-609.

Namyslowska I.  2007.  Risperidone in the Treatment of Children and Adolescents. Psychiatt. Psychol. Klin. 7(1):6-17.

Nagaraj R, Singhi P, Malhi P.  2006.  Risperidone in Children with Autism: Randomized, Placebo-Controlled, Double-Blind Study. J Child Neurol.. 21(6):450-455.

Nag N, Moriuchi JM, Peitzman CGK, Ward BC, Kolodny NH, Berger_Sweeney JE.  2009.  Environment Enrichment Alters Locomotor Behavior and Ventricular Volume in Mecp21lox Mice. Behavioral Brain Research. 196(1):44-48.